REMINDER: Our user survey closes on Friday, please submit your responses here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Looking like a strong Finish to this week ,
Wellcome Diagnostics was a world leader in diagnostic reagent manufacture, but GlaxoWellcome decided to get out of diagnostics. Novacyt may now look like a natural for the GSK stable. But having got out of diagnostics, would they really want to go back there?
Accumulation during morning will move to SP rise into afternoon I think. Similar trend to yesterday. IMO.
Opportunity to top-up?
GLA
trilla1337,
I use IG, did you have to sell the shares and re buy in an ISA. I notice IG take 2-3days to settle on a sharedealing sale, in which time the price could have gone up a reasonable amount.
That was me - I moved my holding into ISA. Two tranches
You have seen the mms malipulation now we are in sets that's stops now no more nasty drops mms scum f em no more big drops you be buying at a lot higher
Glass houses Sharehunter!
how many have sold ,will they pay more to get back in ,
some nice sized share buys gone through ,
and again they moving share price upwards .
Cardinal3 Have given up on mentioning them now even with so much news due .used to be easier to try and guess when one might be released .
Can I be the first to congratulate sharehunter3 on not mentioning RNS in his last post?
Brentw1, don't worry, they will not grind me down, I have been dealing long enough to dismiss the crap, but I do like to point out to them occasionally that they talk crap so they don't get to complacent.
Oh and I find a chocolate Hobnob helps as well ;-)
5000 share buyer again ,
Morning TwoSheds.
I know you only have one shed really (you admitted so a couple of weeks ago) but make yourself a nice cup of coffee and chill out. Maybe it's a nice enough shed to have a comfy chair and you can put your feet up and relax. Don't let the buggers grind you down! :-)
Don't some people on this board talk a load of B******s, they must bang their heads against the wall when they get out of bed in the morning. Why can't they just stfu and let things progress naturally. I am sure all will be rewarded in due course.
if not try why would there be no comment .
like the chunky buys coming through
Novacyt’s rapid expansion and innovation capabilities puts it on the map for a takeover due to foreseeable revenue and growth prospects. Novacyt has become embedded into the NHS and DHSC networks and has some of the highest margins in the industry. Novacyt has an existing working relationship with GSK since their work together on the UK’s high-throughput lab in Cambridge in April 2020.
This has to be addressed soon.
there will be no answer - just no comment- and of course people here will then read hat as a "yes" - this is a rabbit hole you do not wan to go down . its unhelpful as just pushes up the price fro it to fall again - TO rumours are two a penny and a waste of time and effort
SH3, if I was working for Novacyt, and someone sent me an email along the lines that you have suggested, I would burst out laughing and pass it round the office so that all my colleagues could share my amusement. Now be a good chap and go and have a look at the French prices because you have not updated us on those for at least 3 minutes. ;-)
Why would they sell there is most certainly more revenue to come for ncyt
They would only sell if there was £50 per share on the table minimum with share options so a take over just not happening at the moment why under sell ?
And £50 per share would be cheap
No, it would be a rns'd.
if someone who in contact with ncyt could ask is it correct
then be interesting if they receive an answer
when one reads this Article would it not make sense
also from april rns Partnership with AZ, GSK & University of Cambridge